The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study
Chae et al., Tropical Medicine and Infectious Disease, doi:10.3390/tropicalmed7030051
https://c19early.org/chae.html